Images (72)
Showing first 60 of 72 pages.
Document
| id |
id
26413634
|
|---|---|
| contentType |
contentType
document
|
| source |
source
import
|
Source image fields (6)
Extracted text
OCR Page 1 of 72PRIVILEGED AND CONFIDENTIAL -- Attorney Work Product
Prepared by SMBD & DOM for POTUS & USDOJ in Anticipation of Litigation
budget of CTR based upon market share. These secret cost allocations between the tobacco
cartel were again in stark contrast to the Tobacco Companies' public pronouncements that CTR
was truly an independent research entity.
c.
In a 1978 letter from attorney William Shinn of Shook, Hardy & Bacon
to, inter alia, Thomas Ahrensfeld, Ernest Pepples and Arthur Sevens, insisted that future
activities of the Research Liaison Committee should first be reviewed by the Committee of
Counsel for the Tobacco Companies.
d.
A 1980 letter from the President of the Tobacco Institute to various
insurance companies protested discounts being offered to non-smokers and falsely attacked the
credibility of any scientific research showing the hazards of smoking.
e.
A letter dated March 31, 1980 from Bob Seligman of Philip Morris,
U.S.A. to Alex Spears of Lorillard Tobacco Company, specified certain subjects which should
be avoided for tobacco industry research, including inter alia, "attempt[s] to relate human
disease to smoking," though the Defendants previously represented that they would cooperate
with public health officials.
f.
Letters dated May 7, 1982 exchanged between Daniel Milway of the
Tobacco Institute and various presidents of the Tobacco Companies regarding the level of
funding to support independent biomedical research expose the pretense of the Tobacco
Companies purported commitment to independent research as communicated to public officials
and others.
68
Relations
belongs_to